Title:
Panel – A Strategic Overview on the Future of Sterilization
Session Handouts Available at Speaker Approval:
0
Description:
Sterilization is a critical component of medical device production: over 20 billion devices – more than 50% of those regulated by the FDA - have sterility requirements. Yet the industry is facing crisis: ethylene oxide (EO) and gamma sterilization, which have historically comprised 90% of the market both face longterm challenges to their historic dominance of the market.
Substitute modalities with varying degrees of availability, maturity, and sustainability are available: E-Beam, X-ray, Vaporized Hydrogen Peroxide (VHP), and Chlorine Dioxide, to name a few. However, like most critical-to-quality aspects of medical device design, manufacturing, making changes to how existing medical devices are sterilized is typically not simple.
In this panel we will seek to present different views on the future of device sterilization, addressing key strategic questions such as insourcing/outsourcing, modality selection, regulatory strategy, geographical strategy, and some others. Our panelists offer a mix of diverse viewpoints between those providing sterilization services to those consuming them.
Type:
Panel Discussion